FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
On Thursday, the FDA proposed removing oral phenylephrine from the list of approved active ingredients for over-the-counter (OTC) nasal decongestants, citing concerns over its effectiveness. After reviewing available data,
Hosted on MSN1d
FDA Proposes Pulling Ineffective Decongestant From MarketAn FDA advisory committee has unanimously concluded that oral phenylephrine, a decongestant found in many cold and flu ...
"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
The U.S. Food and Drug Administration (FDA) recently held a Patient Engagement Advisory Committee meeting focused on clinical trial informed ...
The Mental Health Watchdog calls for reforms to protect public safety, citing decades of antidepressant, electroshock, and psychedelic drug risks.
A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...
FDA officials said an agency review of the available data found oral phenylephrine is not effective as a nasal decongestant ...
A New York federal judge on Tuesday dismissed about 100 lawsuits that claimed Procter & Gamble , Haleon and other companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback